International Normalized Point of Care Testing for Patients on Anticoagulant Therapies: Clinical Utility and Cost-Effectiveness


( Last Updated : April 27, 2020)
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1466-000

Details


Question


  1.  What is the clinical utility of international normalized ratio point of care testing for patients on anticoagulation therapies?

  2. What is the cost-effectiveness of international normalized ratio point of care testing for patients on anticoagulation therapies?


Key Message

Nine non-randomized studies were identified regarding the clinical utility of international normalized ratio point of care testing for patients on anticoagulation therapies. No relevant economic evaluations were identified regarding the cost-effectiveness of international normalized ratio point of care testing for patients on anticoagulation therapies.